A new tool could help identify gaps in the public's knowledge of blood cancer symptoms – helping to shape future awareness campaigns that could save countless lives.  

Researchers from the University of Surrey and Queen Mary University of London (QMUL) developed a new tool known as Blood Cancer Awareness Measure.

It has been designed to quantify public knowledge of symptoms of blood cancer, including leukaemia, lymphoma, and myeloma, which is the third leading cause of cancer death in the UK.  

Professor Katriina Whitaker, Lead for Cancer Care at the University of Surrey, said:  

"Tools such as these are vital to help improve earlier diagnosis of cancer. Assessing public awareness of cancer symptoms helps us identify knowledge gaps within the population and recommend remedies." 

"Spotting cancer at an early stage saves lives. However, for blood cancer, symptoms are less known, and people often attribute them to other ailments, slowing down the diagnosis process."  

Using the tool, which included a validated online survey and a series of interview questions, researchers found that: 

• Nearly 70 percent of people are not aware night sweats are a symptom of blood cancer and 56 percent did not recognise rashes/itchy skin as an indicator of the disease.  
• Unexplained weight loss (70 percent) and unexplained bleeding (65 percent) were most recognised symptoms of blood cancer.  
• Men had lower knowledge of blood cancer symptoms than women, who were twice as likely to recognise bruising as a sign of the disease.  

As part of their continued work into blood cancer, the research team also investigated the role of patient enablement for those experiencing potential blood cancer symptoms.

Patient enablement is defined as a patient's ability to understand and cope with illness and life after a consultation with a doctor.  

Surveying 434 people, researchers found that 52 percent had experienced at least one potential blood cancer symptom with people reporting an average of two symptoms.

Following a series of questions to determine levels of patient enablement researchers were surprised to find that those who scored highly on patient enablement were less likely to seek help from their GP for potential blood cancer symptoms.

However, enablement was important for re-consultation behaviour (e.g. when symptoms didn't go away), which is important when experiencing blood cancer symptoms, which are often vague and non-specific.   

Rincy George, Policy Officer at Blood Cancer UK, said: "Timely diagnosis is crucial for those facing a blood cancer diagnosis, which is the UK's fifth most common cancer. This new tool is a significant step towards understanding the gaps in public awareness of blood cancer symptoms. By identifying these knowledge gaps, it can help shape impactful awareness campaigns that have the potential to save lives." 

"It remains crucial that people can recognise the signs of blood cancer including unexplained weight loss, drenching night sweats, or itchy skin. If you have any concerns or questions about blood cancer symptoms, don't hesitate to speak to our dedicated specialist nurses on 0808 2080 888." 

Article: Assessing awareness of blood cancer symptoms and barriers to symptomatic presentation: measure development and results from a population survey in the UK

Source: University of Surrey